JP2023526418A5 - - Google Patents
Info
- Publication number
- JP2023526418A5 JP2023526418A5 JP2022570478A JP2022570478A JP2023526418A5 JP 2023526418 A5 JP2023526418 A5 JP 2023526418A5 JP 2022570478 A JP2022570478 A JP 2022570478A JP 2022570478 A JP2022570478 A JP 2022570478A JP 2023526418 A5 JP2023526418 A5 JP 2023526418A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- composition according
- salt
- 25hc3s
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063029364P | 2020-05-22 | 2020-05-22 | |
| US63/029,364 | 2020-05-22 | ||
| US202063030213P | 2020-05-26 | 2020-05-26 | |
| US63/030,213 | 2020-05-26 | ||
| US202063113119P | 2020-11-12 | 2020-11-12 | |
| US63/113,119 | 2020-11-12 | ||
| US202163146556P | 2021-02-05 | 2021-02-05 | |
| US63/146,556 | 2021-02-05 | ||
| PCT/US2021/033746 WO2021237146A1 (en) | 2020-05-22 | 2021-05-21 | Treatment of non-alcoholic steatohepatitis (nash) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526418A JP2023526418A (ja) | 2023-06-21 |
| JP2023526418A5 true JP2023526418A5 (enExample) | 2024-05-28 |
Family
ID=78707648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570478A Pending JP2023526418A (ja) | 2020-05-22 | 2021-05-21 | 非アルコール性脂肪性肝炎（ｎａｓｈ）の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230181602A1 (enExample) |
| EP (1) | EP4153165A4 (enExample) |
| JP (1) | JP2023526418A (enExample) |
| KR (1) | KR20230015940A (enExample) |
| CN (1) | CN115803061A (enExample) |
| AU (1) | AU2021273937A1 (enExample) |
| BR (1) | BR112022023128A2 (enExample) |
| CA (1) | CA3183119A1 (enExample) |
| MX (1) | MX2022014574A (enExample) |
| TW (1) | TW202210082A (enExample) |
| WO (1) | WO2021237146A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3494125B1 (en) | 2016-08-02 | 2022-06-22 | Virginia Commonwealth University | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide |
| KR20260004765A (ko) * | 2024-07-02 | 2026-01-09 | 건국대학교 글로컬산학협력단 | 스타틴이 결합된 담즙산을 포함하는 대사성 질환의 예방 또는 치료용 약학적 조성물 및 이의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006047022A1 (en) * | 2004-10-25 | 2006-05-04 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US8399441B2 (en) * | 2004-10-25 | 2013-03-19 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| US9034859B2 (en) * | 2011-04-06 | 2015-05-19 | Virginia Commonwealth University | Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation |
| US9889108B2 (en) * | 2013-03-15 | 2018-02-13 | Mochida Pharmaceutical Co., Ltd. | Compositions and methods for treating non-alcoholic steatohepatitis |
| EP3493810A4 (en) * | 2016-08-02 | 2020-04-08 | Durect Corporation | COMPOSITIONS WITH OXYGENOUS CHOLESTERINSULFATE AND AT LEAST POLYALKYLENE GLYCOL, CARBOXYMETHYLCELLULOSE OR POLYOXYL GLYCERIDE |
| JP7266531B2 (ja) * | 2017-04-18 | 2023-04-28 | ジェンフィ | エラフィブラノール又はその誘導体と抗ｎａｓｈ剤、抗線維化剤又は抗胆汁うっ滞性剤の組合せ |
| US10980810B2 (en) * | 2017-10-06 | 2021-04-20 | Gilead Sciences, Inc. | Combination therapy comprising an ACC inhibitor |
-
2021
- 2021-05-21 JP JP2022570478A patent/JP2023526418A/ja active Pending
- 2021-05-21 EP EP21809835.8A patent/EP4153165A4/en active Pending
- 2021-05-21 BR BR112022023128A patent/BR112022023128A2/pt not_active Application Discontinuation
- 2021-05-21 TW TW110118459A patent/TW202210082A/zh unknown
- 2021-05-21 US US17/924,103 patent/US20230181602A1/en active Pending
- 2021-05-21 CN CN202180049250.2A patent/CN115803061A/zh active Pending
- 2021-05-21 WO PCT/US2021/033746 patent/WO2021237146A1/en not_active Ceased
- 2021-05-21 KR KR1020227043977A patent/KR20230015940A/ko active Pending
- 2021-05-21 MX MX2022014574A patent/MX2022014574A/es unknown
- 2021-05-21 CA CA3183119A patent/CA3183119A1/en active Pending
- 2021-05-21 AU AU2021273937A patent/AU2021273937A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101465715B1 (ko) | 심혈관 이벤트 발병 예방용 조성물 | |
| HRP20250797T1 (hr) | Postupci za liječenje pacijenata s obiteljskom hiperkolesterolemijom | |
| JP2019048843A5 (enExample) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| RU2008144136A (ru) | Твердая пероральная лекарственная форма, содержащая усилитель | |
| JP2012176987A (ja) | 脂質療法用のオメガ−３脂肪酸類及び異常脂質血症薬剤 | |
| US6673831B1 (en) | Combination therapy for reducing the risks associated with cardiovascular disease | |
| CA2251972A1 (en) | Combination therapy for reducing the risks associated with cardiovascular disease | |
| JP2018508551A5 (ja) | 心血管疾患を処置するか又は心血管疾患のリスクを低減させるためのｅｔｃ１００２及び１種以上のスタチンを含む固定用量組合せ物 | |
| JP2024507810A5 (enExample) | ||
| JP2023526418A5 (enExample) | ||
| CN101939001B (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| IL274414B2 (en) | Oral rifamycin sv compositions | |
| JP2023538522A5 (enExample) | ||
| IL310115A (en) | Treatment of his hyporesponders | |
| JP2023522415A5 (enExample) | ||
| JP2023527153A5 (enExample) | ||
| WO2013073884A1 (en) | Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability | |
| JP2022177119A5 (enExample) | ||
| WO2006062933A2 (en) | Stable compositions of fenofibrate with fatty acid esters | |
| US6890941B1 (en) | Compositions containing HMG Co-A reductase inhibitors and policosanol | |
| RU2007149337A (ru) | Новый способ лечения гиперлипидемии | |
| KR20020025066A (ko) | ＨＭＧ-ＣｏＡ 리덕타제 억제제 및 카르니틴을 포함하는항지질혈성 복합제 | |
| CN102416015A (zh) | 一种含他汀类药物的组合物及其用途 | |
| CN101897967A (zh) | 一种治疗血脂异常的沙棘黄酮复方制剂 |